Neuronetics Inc (NASDAQ:STIM) currently has a daily average trading volume of 1.54M but it saw 1256281 shares traded in last market. With a market cap of 163.48M USD, the company’s current market price of $4.08 came falling about -6.64 while comparing to the previous closing price of $4.37. In past 52 weeks, the stock remained buoying in the range of price level as high as $5.92 and as low as $0.52. In the recent trading on the day, stock has struck highest price mark of $4.065 while lowest mark touched by it was $4.43.
Taking a look at 20-day trading activity of Neuronetics Inc (STIM) gives us an average price of $4.68, while its current price level is -31.08% below from 52-week high level whereas it is 684.62% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $3.92 while that of 200 days or SMA-200 reads an average of $1.93. A closer look into the stock’s movement over the week reveals that its volatility is standing at 8.24% during that period while stretching the period over a month that increases to 11.58%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 44.60 which implies that the stock is in neutral territory.
Over the week, STIM’s stock price is moving -18.56% down while it is -5.77% when we observe its performance for the past one month. Year-to-date it is 153.42% up and over the past year, the stock is showing a downside performance of -3.55%.
The company is expected to be releasing its next quarterly report on 2025-Mar-03, for which analysts forecasted an EPS of -0.12 while estimate for next year EPS is -0.3. In next quarter, company is expected to be making quarterly sales of $36.69M as analysts are expecting the sales for current fiscal year at $148.57M and seeing the company making $163.17M in sales next year. Moreover, analysts are in estimates of $29.07M for current-quarter revenue.
Currently, Neuronetics Inc’s total number of outstanding shares is 55.68M with 9.44% of that held by the insiders while 57.90% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -40.74% and return on equity (ROE) at -138.47%. Stock’s beta reads 1.93. Stock has a price to book (P/B) ratio of 8.05 while price to sale or P/S ratio amounts to 2.18. Its return on asset (ROA) is -34.66% on average.
